Connect with us

Health

Drug combination could make curative surgery possible for some liver cancer patients – News-Medical.net

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible…

Published

on

Article feature image

A combination of the kinase-inhibitor drug cabozantinib and the immunotherapy drug nivolumab can make curative surgery possible in some liver cancer patients who would normally not be considered surgery candidates.
Results published July 29 in the journal…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending